195 related articles for article (PubMed ID: 8588500)
1. Gas chromatographic procedure for simultaneous determination of selegiline metabolites, amphetamine, methamphetamine and demethyl-deprenyl in pig plasma.
Szebeni G; Lengyel J; Székács G; Magyar K; Gaál J; Szatmári I
Acta Physiol Hung; 1995; 83(2):135-41. PubMed ID: 8588500
[TBL] [Abstract][Full Text] [Related]
2. Pharmacokinetics and bioequivalence of the main metabolites of selegiline: desmethylselegiline, methamphetamine and amphetamine after oral administration of selegiline.
Mascher HJ; Kikuta C; Millendorfer A; Schiel H; Ludwig G
Int J Clin Pharmacol Ther; 1997 Jan; 35(1):9-13. PubMed ID: 9021435
[TBL] [Abstract][Full Text] [Related]
3. Determination of amphetamine, methamphetamine and desmethyldeprenyl in human plasma by gas chromatography/negative ion chemical ionization mass spectrometry.
Reimer ML; Mamer OA; Zavitsanos AP; Siddiqui AW; Dadgar D
Biol Mass Spectrom; 1993 Apr; 22(4):235-42. PubMed ID: 8481411
[TBL] [Abstract][Full Text] [Related]
4. Multiple-dose pharmacokinetics of selegiline and desmethylselegiline suggest saturable tissue binding.
Laine K; Anttila M; Huupponen R; Mäki-Ikola O; Heinonen E
Clin Neuropharmacol; 2000; 23(1):22-7. PubMed ID: 10682227
[TBL] [Abstract][Full Text] [Related]
5. A new formulation of selegiline: improved bioavailability and selectivity for MAO-B inhibition.
Clarke A; Brewer F; Johnson ES; Mallard N; Hartig F; Taylor S; Corn TH
J Neural Transm (Vienna); 2003 Nov; 110(11):1241-55. PubMed ID: 14628189
[TBL] [Abstract][Full Text] [Related]
6. l-methamphetamine pharmacokinetics and pharmacodynamics for assessment of in vivo deprenyl-derived l-methamphetamine.
Melega WP; Cho AK; Schmitz D; Kuczenski R; Segal DS
J Pharmacol Exp Ther; 1999 Feb; 288(2):752-8. PubMed ID: 9918585
[TBL] [Abstract][Full Text] [Related]
7. Detection, quantification, metabolism, and behavioral effects of selegiline in horses.
Dirikolu L; Lehner AF; Karpiesiuk W; Hughes C; Woods WE; Boyles J; Harkins JD; Troppmann A; Tobin T
Vet Ther; 2003; 4(3):257-68. PubMed ID: 15136987
[TBL] [Abstract][Full Text] [Related]
8. Quantitative analysis of selegiline and three metabolites (N-desmethylselegiline, methamphetamine, and amphetamine) in human plasma by high-performance liquid chromatography-atmospheric pressure chemical ionization-tandem mass spectrometry.
Slawson MH; Taccogno JL; Foltz RL; Moody DE
J Anal Toxicol; 2002 Oct; 26(7):430-7. PubMed ID: 12422997
[TBL] [Abstract][Full Text] [Related]
9. CYP2D6 polymorphism is not crucial for the disposition of selegiline.
Scheinin H; Anttila M; Dahl ML; Karnani H; Nyman L; Taavitsainen P; Pelkonen O; Bertilsson L
Clin Pharmacol Ther; 1998 Oct; 64(4):402-11. PubMed ID: 9797797
[TBL] [Abstract][Full Text] [Related]
10. Pharmacokinetic studies of (-)-deprenyl and some of its metabolites in mouse.
Magyar K; Szatmáry I; Szebeni G; Lengyel J
J Neural Transm Suppl; 2007; (72):165-73. PubMed ID: 17982891
[TBL] [Abstract][Full Text] [Related]
11. Sensitive high-performance liquid chromatographic method for the determination of the three main metabolites of selegiline (L-deprenyl) in human plasma.
La Croix R; Pianezzola E; Strolin Benedetti M
J Chromatogr B Biomed Appl; 1994 Jun; 656(1):251-8. PubMed ID: 7952037
[TBL] [Abstract][Full Text] [Related]
12. Bioequivalence evaluation of two preparations containing the highly variable compound selegiline (L-deprenyl).
Waitzinger J; Ludwig G; Pabst G; Michaelis K; Reh C
Int J Clin Pharmacol Ther; 1996 Oct; 34(10):427-32. PubMed ID: 8897080
[TBL] [Abstract][Full Text] [Related]
13. Pharmacokinetics of selegiline, R-methamphetamine, R-amphetamine, and desmethylselegiline in oral fluid after a single oral administration of selegiline.
Chen L; Shen B; Wang S; Yu Y; Yan H; Shi Y; Duan G; Xiang P
Drug Test Anal; 2019 Jun; 11(6):898-905. PubMed ID: 30614204
[TBL] [Abstract][Full Text] [Related]
14. Pharmacokinetic evaluation of a selegiline pulsatile oral delivery system.
Rohatagi S; Barrett JS; DeWitt KE; Lessard D; Morales RJ
Biopharm Drug Dispos; 1997 Nov; 18(8):665-80. PubMed ID: 9373724
[TBL] [Abstract][Full Text] [Related]
15. Lack of pharmacokinetic interaction between the selective dopamine agonist cabergoline and the MAO-B inhibitor selegiline.
Dostert P; Strolin Benedetti M; Persiani S; La Croix R; Bosc M; Fiorentini F; Deffond D; Vernay D; Dordain G
J Neural Transm Suppl; 1995; 45():247-57. PubMed ID: 8748632
[TBL] [Abstract][Full Text] [Related]
16. Stereochemical determination of selegiline metabolites in postmortem biological specimens.
Kupiec TC; Chaturvedi AK
J Forensic Sci; 1999 Jan; 44(1):222-6. PubMed ID: 9987891
[TBL] [Abstract][Full Text] [Related]
17. Integrated pharmacokinetic and metabolic modeling of selegiline and metabolites after transdermal administration.
Rohatagi S; Barrett JS; DeWitt KE; Morales RJ
Biopharm Drug Dispos; 1997 Oct; 18(7):567-84. PubMed ID: 9330778
[TBL] [Abstract][Full Text] [Related]
18. Effect of concomitant hormone replacement therapy containing estradiol and levonorgestrel on the pharmacokinetics of selegiline.
Palovaara S; Anttila M; Nyman L; Laine K
Eur J Clin Pharmacol; 2002 Jul; 58(4):259-63. PubMed ID: 12136372
[TBL] [Abstract][Full Text] [Related]
19. Reduced cardiovascular effects of methamphetamine following treatment with selegiline.
Schindler CW; Gilman JP; Graczyk Z; Wang G; Gee WL
Drug Alcohol Depend; 2003 Nov; 72(2):133-9. PubMed ID: 14636968
[TBL] [Abstract][Full Text] [Related]
20. Methamphetamine and amphetamine derived from the metabolism of selegiline.
Romberg RW; Needleman SB; Snyder JJ; Greedan A
J Forensic Sci; 1995 Nov; 40(6):1100-2. PubMed ID: 8522918
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
